Timing of transition from mechanical thrombectomy to intra-arterial alteplase and reperfusion quality in thrombectomy-refractory stroke.
Kim Kyeongsik K, Lee Su Ji SJ, Lee Joonwon J, Lee Hyungon H et al.
Mechanical thrombectomy (MT) is the standard treatment for acute ischemic stroke due to large vessel occlusion (LVO), but a subset of lesions remains refractory or technically challenging despite repeated mechanical attempts. Intra-arterial (IA) alteplase may be used as rescue therapy, but the optimal timing of transition from mechanical to pharmacological therapy remains unclear. We examined the association between the timing of this transition and reperfusion quality. We retrospectively reviewed 90 consecutive patients with LVO treated with MT between July 2021 and December 2022. Sixteen patients received rescue IA alteplase after ineffective or unfeasible MT. Procedure time was divided into an MT phase (femoral puncture to IA alteplase initiation) and an IA phase (IA alteplase initiation to the end of the procedure). The primary outcome was excellent reperfusion, defined as modified Thrombolysis in Cerebral Infarction (mTICI) 2c-3. Successful reperfusion (mTICI ≥2b) was achieved in 15 patients (93.8%), including excellent reperfusion in 8 (50.0%). The MT phase was shorter in the excellent than in the non-excellent reperfusion group (median, 49.5 vs. 87.5 minutes; p=0.028), whereas the difference in the IA phase was not statistically significant (36.5 vs. 75.5 minutes; p=0.068). No symptomatic intracerebral hemorrhage occurred. Good functional outcome (modified Rankin Scale ≤2) at 3 months was observed in 2 patients (12.5%). In this exploratory series, a shorter period of MT before transition to IA alteplase was associated with excellent reperfusion. This hypothesis-generating finding suggests that the timing of transition may matter and warrants evaluation in larger, controlled studies.